Lava Therapeutics B.V. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Lava Therapeutics B.V. | LVTX - NASDAQ |
$14.00-$16.00 | $15.00 | $12.00 | 6.7 million | 3/25/2021 |
| JP Morgan, Jefferies, SVB Leerink | ||||||
Co-Manager(s): Kempen & Co
| ||||||
| Health Care | ||||||
Filing(s): Filed 2021-03-02 Terms Added 2021-03-18 | ||||||
Lava Therapeutics B.V. Quote & Chart - Click for current quote - LVTX
IPO Boutique aggregates information on public companies and private companies, such as "LVTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Lava Therapeutics B.V. (adapted from Lava Therapeutics B.V. prospectus):
They are a biotechnology company focused on transforming cancer treatment by developing a platform of novel bispecific antibodies engineered to selectively induce gamma-delta T cell-mediated immunity against tumor cells.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a biotechnology company focused on transforming cancer treatment by developing a platform of novel bispecific antibodies engineered to selectively induce gamma-delta T cell-mediated immunity against tumor cells.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "LVTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.